InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Lawlis V Bryan, 董事. Director active across 2 companies, notably Biomarin Pharmaceutical INC. In total, 9 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 9 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lawlis V Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
13,300 股@ US$1.17812.5% 占其流量Common StockSEC:0000886744-25-000013:0
标准退出：2025年8月7日 (T+90)
35,000 股@ US$1.9455.9% 占其流量Common StockSEC:0000950170-24-061615:0
4,190 股0Common StockSEC:0001209191-23-031973:0
35,000 股@ US$1.1031.6% 占其流量Common StockSEC:0001062993-23-010852:0
8,500 股@ US$67.8155.4% 占其流量Common StockSEC:0001209191-23-023062:0
4,980 股0Common StockSEC:0001567619-22-011796:0
4,250 股@ US$37.460.0013% mcap34.6% 占其流量Common StockSEC:0001567619-22-008633:0
4,250 股@ US$37.4617.1% 占其流量Common StockSEC:0001567619-22-001334:0
5,120 股0Common StockSEC:0001567619-21-011314:0
9 条申报中的 9 条
About Lawlis V Bryan
Bryan V. Lawlis is a Director at BIOMARIN PHARMACEUTICAL INC. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for BIOMARIN.
